Diflorasone

Diflorasone (CAS No.: 2557-49-5) is a synthetic fluorinated glucocorticoid and corticosteroid receptor agonist that is widely classified as an anti inflammatory and immunoregulatory research tool in immunology dermatology and inflammation biology, with experimental relevance to cutaneous vasoconstriction and cytokine driven disease models; mechanistically it diffuses across cellular membranes and binds the cytoplasmic glucocorticoid receptor NR3C1, after which the ligand receptor complex translocates to the nucleus to regulate glucocorticoid response element dependent transcription, typically increasing expression of anti inflammatory regulators such as NFKB inhibitory proteins while suppressing pro inflammatory mediators including interleukin 1 interleukin 2 and interleukin 6 associated signaling outputs and downstream T lymphocyte activation programs, thereby providing a robust platform for studying steroid responsive gene networks and immune cell functional plasticity; in vitro characterization in the literature for glucocorticoid class compounds generally places functional activity in nanomolar to micromolar concentration ranges depending on cell context receptor abundance and assay endpoint, and when direct assay specific potency values are not consistently reported for this compound researchers commonly determine concentration response windows empirically in receptor transactivation cytokine suppression and inflammation associated reporter systems; typical preclinical use includes mechanistic studies in keratinocyte fibroblast and immune cell models as well as inflammation related animal paradigms relevant to psoriasis like and dermatitis like phenotypes, where the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives and are selected to balance pathway modulation signal strength and model specific tolerability within strictly nonclinical research settings.